Inspiremd receives ce mark recertification under eu's new medical device regulation (mdr) regulatory framework

Tel aviv, israel and miami, jan. 31, 2024 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention carotid stent system (eps) for the prevention of stroke, today announced that it has received ce mark recertification under the european union's new medical device regulation (mdr) regulatory framework. mdr replaced the previous mdd framework, which had governed the approval and marketing of medical devices in the eu until may of 2021.
NSPR Ratings Summary
NSPR Quant Ranking